XML 33 R32.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Equity (Tables)
3 Months Ended
Dec. 31, 2019
Equity [Abstract]  
Schedule of Stock-based Compensation Expense - By Award Type

The effect of recording stock-based compensation expense was as follows:

 

 

 

 

 

 

 

 

 

For the three months

Stock-based Compensation Expense - by award type

 

ended December 31, 

(in thousands)

    

2019

    

2018

Employee stock options

 

$

 5

 

$

 7

Restricted stock units and awards

 

 

376

 

 

386

Performance stock units and awards

 

 

292

 

 

(60)

Employee stock purchase plan

 

 

47

 

 

40

Outside director equity awards and fees in common stock

 

 

81

 

 

52

Total stock-based compensation expense

 

$

801

 

$

425

 

Schedule of Stock-based Compensation Expense - By Expense Type

 

 

 

 

 

 

 

 

 

For the three months

Stock-based Compensation Expense - by expense type

 

ended December 31, 

(in thousands)

    

2019

    

2018

Cost of revenue

 

$

136

 

$

111

Selling, general, and administrative

 

 

485

 

 

159

Research and development

 

 

180

 

 

155

Total stock-based compensation expense

 

$

801

 

$

425

 

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the computation of basic and diluted net loss per share:

 

 

 

 

 

 

 

 

 

For the three months

Basic and Diluted Net Loss Per Share

 

ended December 31, 

(in thousands, except per share)

    

2019

    

2018

Numerator:

 

 

  

 

 

  

Loss from continuing operations

 

$

(1,335)

 

$

(5,538)

Undistributed earnings allocated to common shareholders for basic and diluted net income per share

 

 

(1,335)

 

 

(5,538)

Denominator:

 

 

  

 

 

  

Denominator for basic and fully diluted net loss per share - weighted average shares outstanding

 

 

28,832

 

 

27,534

 

 

 

 

 

 

 

Net loss per basic and fully diluted share

 

$

(0.05)

 

$

(0.20)

 

 

 

 

 

 

 

Weighted average antidilutive options, unvested restricted stock units and awards, unvested performance stock units and ESPP shares excluded from the computation

 

 

1,168

 

 

664

 

Schedule of Common Stock Reserved for Future Issuances

As of December 31, 2019, we had common stock reserved for the following future issuances:

 

 

 

 

    

Number of Common

 

 

Stock Shares Available for

Future Issuances

 

Future Issuances

Exercise of outstanding stock options

 

48,684

Unvested restricted stock units and awards

 

1,754,697

Unvested performance stock units and awards (at 200% maximum payout)

 

1,812,000

Purchases under the employee stock purchase plan

 

543,731

Issuance of stock-based awards under the Equity Plans

 

1,126,981

Purchases under the officer and director share purchase plan

 

88,741

Total reserved

 

5,374,834